Isogenica Limited is a biotechnology company based in Little Chesterford, United Kingdom, specializing in the design and licensing of synthetic antibody libraries and display technologies for antibody discovery. Established in 1998 and formerly known as Pharmacophorix Limited, Isogenica offers a range of products including the llamdA System, a single-domain antibody library; the Xab System, which features fully and semi-synthetic human antibody fragments; and the 4D Fab System, a synthetic human antibody library. The company also provides peptide and scaffold platforms aimed at facilitating the development of therapeutic peptides for various diseases. Isogenica’s technologies, including its CIS display, are utilized by pharmaceutical and biotechnology companies to create versatile small-format antibodies, enabling the construction of biotherapeutics for cancer, inflammation, and other serious conditions. This innovative approach supports the creation of bispecific and multi-specific biotherapeutics, enhancing targeted drug delivery in medical research and therapeutic applications.
Karyon, Ltd. develops peptides into carriers for use in cancer diagnostics, imaging, and therapy. It offers Karyon Targeting Unit, a synthetic peptide that targets specific tumor tissue. The company engages in the areas of cancer biology and cell growth regulation, angiogenesis, biochemistry, peptide chemistry, organic syntheses and immunohistochemistry. Karyon, Ltd. was founded in 2001 and is based in Helsinki, Finland. As of May 6, 2008, Karyon Ltd. operates as a subsidiary of Isogenica Limited.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.